Cytosorbents (CTSO) Misses Q1 EPS by 7c

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $11.5 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance